Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

5.92
Delayed Data
As of Feb 12
 +0.36 / +6.47%
Today’s Change
5.24
Today|||52-Week Range
16.98
-24.59%
Year-to-Date

Today’s Trading

Previous close5.56
Today’s open5.65
Day’s range5.32 - 5.93
Volume433,244
Average volume (3 months)933,295
Market cap$273.7M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+86.36%
Earnings growth (this year)--
Earnings growth (next 5 years)+101.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales4.97
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...+0.45+6.22%
OMEDOncoMed Pharmaceutic...+0.16+1.77%
ADMSAdamas Pharmaceutica...+0.79+5.84%
PGNXProgenics Pharmaceut...-0.06-1.47%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 23, 2016
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$165.0M
Annual profit (last year)-$17.4M
Net profit margin-10.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Adelene Q. Perkins
CFO, Secretary, Treasurer &
CAO
Lawrence E. Bloch
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers